TITLE

The Future of Pharmacology: Towards More Personalized Pharmacotherapy and Reverse Translational Research

AUTHOR(S)
von Gunten, Stephan
PUB. DATE
January 2020
SOURCE
Pharmacology;Jan2020, Vol. 105 Issue 1/2, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
Clinical pharmacology, in particular in terms of pharmacogenomics and therapeutic drug monitoring, has played a pioneering role in precision medicine [[5]]. Challenges remain for the pharmacologist to better understand the mechanisms of certain established drugs, such as the pluripotent anti-inflammatory effects of steroids or high-dose intravenous immunoglobulin preparations [[12]]. Thus, there is a call for the modern pharmacologist to actively engage in basic and translational research and for the field to adopt new domains that were not traditionally linked to pharmacology.
ACCESSION #
141337513

 

Related Articles

  • MEDICAL AND PHARMACEUTICAL LAW: ANALYSIS CLINICAL AND PHARMACOLOGICAL GROUP DRUGS USED IN PHARMACOTHERAPY CARDIAC DISEASES FORMULARY SYSTEM WITHIN RUSSIA AND UKRAINE. SHAPOVALOV, V. V. (Yur. ).; RYSCHENKO, O. A.; SHAPOVALOV, V. V.; KAPIELNIKOVA, E. V.; SHAPOVALOVA, V. A. // Belgorod State University Scientific Bulletin: Medicine, Pharmac;2014, Vol. 28 Issue 24, p137 

    The article presents the results of an analysis of clinical and pharmacological groups of drugs used in the pharmacotherapy of heart disease within the formulary system of Russia and Ukraine in terms of international - anatomical therapeutic chemical classification system and medicines of WHO...

  • The Fifth International Neurological Congress in Lisbon, 1953. Tychala, Christina-Areti; Triarhou, Lazaros C. // European Neurology;2018, Vol. 80 Issue 5/6, p321 

    We present an overview of the International Neurological Congress that was held in Lisbon, Portugal, on September 7–12, 1953, the fifth in the series of meetings that became a tradition and helped to establish Neurology and Neurosurgery as independent medical specialties in the...

  • New antimuscarinic agent approved for overactive bladder. LoBuono, Charlotte // Drug Topics;1/24/2005, Vol. 149 Issue 2, p16 

    This article evaluates the drug darifenacin, manufactured by Novartis Pharmaceuticals Corp. and proved by the U.S. Food and Drug Administration, a new antimuscarinic agent for overactive bladder (OAB). An explanation is given by William Steers, the Hovey Dabney Professor of Urology and chair of...

  • CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. Dietrich, Joerg; Han, Ruolan; Yin Yang; Mayer-Pröschel, Margot; Noble, Mark // Journal of Biology;2006, Vol. 5, p1 

    Background: Chemotherapy in cancer patients can be associated with serious short- and long-term adverse neurological effects, such as leukoencephalopathy and cognitive impairment, even when therapy is delivered systemically. The underlying cellular basis for these adverse effects is poorly...

  • HYPERTENSION OF RENAL ORIGIN RESPONDING TO CHLORPROMAZINE AND RAUWOLFIA. Morrell, Roger Merritt; Hitzrot, James Morley // Angiology;Jun1956, Vol. 7 Issue 3, p243 

    1. A case of azotemic renal hypertension is presented. 2. The effects of Thorazine on blood pressure in this case are described. 3. It is suggested that Thorazine, in addition to diet, bedrest, sedation, and present drug therapy, may be beneficial in such cases. 4. Pharmacologic mechanisms are...

  • Practice Guidelines for Transdermal Opioids in Malignant Pain. Skaer, Tracy L. // Drugs;2004, Vol. 64 Issue 23, p2629 

    Patients with moderate-to-severe malignancy-related pain require opioid pharmacotherapy. Many cancer patients continue to be prescribed subtherapeutic doses of pain medications resulting in undue suffering and diminished quality of life. Pain associated with malignancy and its treatment may...

  • Eplerenone: A Review of its Use in Left Ventricular Systolic Dysfunction and Heart Failure After Acute Myocardial Infarction. Keating, Gillian M.; Plosker, Greg L. // Drugs;2004, Vol. 64 Issue 23, p2689 

    Eplerenone (Inspraâ„¢) is a selective aldosterone blocker. Oral eplerenone is approved for use in patients with left ventricular (LV) systolic dysfunction and clinical evidence of heart failure following acute myocardial infarction (MI) in the US and in European countries (e.g. the UK and...

  • Quantitative Systems Pharmacology Approaches Applied to Microphysiological Systems (MPS): Data Interpretation and Multi-MPS Integration. Yu, J; Cilfone, NA; Large, EM; Sarkar, U; Wishnok, JS; Tannenbaum, SR; Hughes, DJ; Lauffenburger, DA; Griffith, LG; Stokes, CL; Cirit, M // CPT: Pharmacometrics & Systems Pharmacology;Oct2015, Vol. 4 Issue 10, p585 

    Our goal in developing Microphysiological Systems (MPS) technology is to provide an improved approach for more predictive preclinical drug discovery via a highly integrated experimental/computational paradigm. Success will require quantitative characterization of MPSs and mechanistic analysis of...

  • Efficacy and safety of azithromycin for uncomplicated typhoid fever: An open label non-comparative study. Aggarwal, Anju; Ghosh, Apurba; Gomber, Sunil; Mitra, Monjori; Parikh, A. // Indian Pediatrics;Jul2011, Vol. 48 Issue 7, p553 

    n open-labelled, non-comparative study was conducted in 117 children aged 2-12 years to evaluate the efficacy and safety of azithromycin (20mg/ kg/day for 6 days) for the treatment of uncomplicated typhoid fever. Of the patients enrolled based on a clinical definition of typhoid fever, 109...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics